CLINICAL_TRIALS
trial_result
· 2019-12-30
Clinical Trial Update: A Long-term Trial of OPC-34712 in Patients With Schizophrenia [Phase 3]
Summary
A long-term Phase 3 clinical trial of OPC-34712 in schizophrenia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2019-12-30